Fig. 2. Overview of K-MMSE scores for patients with testosterone deficiency syndrome, stratified according to whether they received testosterone replacement therapy (TRT group, n=13) or a placebo (control group, n=12). Only data for patients with cognitive impairment at baseline (K-MMSE score <25) are given. At 8 months after intervention, the K-MMSE scores improved significantly (^*) in the TRT group but not in the control group. ^*p<0.05 compared with baseline values. K-MMSE: Korean Mini-Mental State Examination.